7Baggers
 Transcript : BioNTech SE - Special Call  MarketScreener Mon, 17 Nov 2025 18:08:43 GMT
 Pfizer cuts BioNTech stake by 54.7 percent  Medical Dialogues Mon, 17 Nov 2025 11:51:10 GMT
 BIONTECH : Berenberg reiterates its Buy rating  MarketScreener Mon, 17 Nov 2025 07:13:29 GMT
 (BNTX) Movement Within Algorithmic Entry Frameworks  news.stocktradersdaily.com Fri, 14 Nov 2025 18:00:02 GMT
 Pfizer Cuts BioNTech Stake by More Than Half  Yahoo Finance Fri, 14 Nov 2025 11:41:52 GMT
 pfizer slashes stake in covid vaccine partner biontech  ETPharma.com Fri, 14 Nov 2025 06:10:03 GMT
 Pfizer slashes stake in COVID vaccine partner BioNTech  Reuters Thu, 13 Nov 2025 23:43:30 GMT
 Pfizer Plans to Divest BioNTech Stake, Impacting BNTX Shares  GuruFocus Thu, 13 Nov 2025 14:14:21 GMT
 BioNTech (BNTX) Concludes Successful Stock Offering  GuruFocus Thu, 13 Nov 2025 14:14:20 GMT
 Evercore ISI Reaffirms Their Buy Rating on BioNTech SE (BNTX)  The Globe and Mail Thu, 13 Nov 2025 13:44:41 GMT
 Pfizer to Sell BioNTech Stake, Sources Tell Bloomberg  MarketScreener Thu, 13 Nov 2025 11:46:27 GMT
 Pfizer Looks to Sell Stake in Pandemic Vaccine Partner BioNTech  Bloomberg.com Thu, 13 Nov 2025 11:03:32 GMT
 A Closer Look at BioNTech's Options Market Dynamics  Benzinga Wed, 12 Nov 2025 18:01:57 GMT
 BioNTech Unveils Strategic Advances at R&D Day 2025  TipRanks Wed, 12 Nov 2025 13:17:57 GMT
 biontech : jefferies reiterates its buy rating  MarketScreener Wed, 12 Nov 2025 06:29:29 GMT
 BioNTech’s Impressive Q3 Performance: What’s Next?  timothysykes.com Tue, 11 Nov 2025 19:33:00 GMT
 biontech price shows more positive signs - forecast today - 11-11-2025  Economies.com Tue, 11 Nov 2025 12:38:00 GMT
 biontech (bntx): hc wainwright & co. raises price target to $140  GuruFocus Mon, 10 Nov 2025 12:51:50 GMT
 biontech : ubs is neutral  MarketScreener Fri, 07 Nov 2025 12:08:35 GMT
 ubs maintains neutral rating on bntx, raises price target to $11  GuruFocus Thu, 06 Nov 2025 18:04:56 GMT
 biontech price target raised to $117 from $115 at ubs  TipRanks Thu, 06 Nov 2025 13:40:38 GMT
 why biontech stock jumped by nearly 4% on wednesday  MSN Thu, 06 Nov 2025 10:37:57 GMT
 biontech se reports q3 2025 financial results  MSN Wed, 05 Nov 2025 22:03:51 GMT
 biontech’s earnings call: progress amid challenges  TipRanks Wed, 05 Nov 2025 00:54:38 GMT
 biontech (nasdaq:bntx) announces quarterly earnings results  MarketBeat Tue, 04 Nov 2025 13:37:14 GMT
 BioNTech SE (NASDAQ:BNTX) Q3 2025 Earnings Call Transcript  Insider Monkey Tue, 04 Nov 2025 13:24:06 GMT
 biontech price target raised to $134 from $130 at bofa  TipRanks Tue, 04 Nov 2025 12:37:37 GMT
 biontech se reports q3 2025 financial results  TipRanks Tue, 04 Nov 2025 04:07:58 GMT
 biontech : jefferies gives a buy rating  MarketScreener Mon, 03 Nov 2025 21:46:27 GMT
 biontech: 2025 guidance upgraded; oncology pipeline advances  MarketScreener Mon, 03 Nov 2025 19:59:15 GMT
 how (bntx) movements inform risk allocation models  news.stocktradersdaily.com Mon, 03 Nov 2025 16:44:01 GMT
 transcript : biontech se, q3 2025 earnings call, nov 03, 2025  MarketScreener Mon, 03 Nov 2025 15:20:43 GMT
 biontech : q3 2025 earnings presentation  MarketScreener Mon, 03 Nov 2025 12:37:07 GMT
 biontech (bntx) reports q3 revenue growth despite eps loss  GuruFocus Mon, 03 Nov 2025 12:32:01 GMT
 biontech : q3 2025 finanzbericht  MarketScreener Mon, 03 Nov 2025 12:19:13 GMT
 biontech shares rise as revenue surge offsets earnings miss  Investing.com Mon, 03 Nov 2025 11:57:34 GMT
 biontech's q3 revenue jumps 22% to €1.52b  breakingthenews.net Mon, 03 Nov 2025 11:46:00 GMT
 BioNTech Raises Sales Outlook on Boost from Bristol Payments  Bloomberg.com Mon, 03 Nov 2025 08:00:00 GMT
 BioNTech SE Reports Q3 2025 Financial Results  TipRanks Mon, 03 Nov 2025 08:00:00 GMT
 BioNTech SE (BNTX) Misses Q3 EPS by 22c; lifts guidance  StreetInsider Mon, 03 Nov 2025 08:00:00 GMT
 BioNTech SE Increases Earnings Guidance for the Year 2025  MarketScreener Mon, 03 Nov 2025 08:00:00 GMT
 biontech q3 2025 earnings call transcript  MarketBeat Mon, 03 Nov 2025 08:00:00 GMT

BioNTech SE
(NASDAQ:BNTX) 

BNTX stock logo

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa...

Founded: 2008
Full Time Employees: 1,800
CEO / Founder: Ugur Sahin 
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends